Fei Peng

3.3k total citations
49 papers, 1.7k citations indexed

About

Fei Peng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fei Peng has authored 49 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Fei Peng's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Microtubule and mitosis dynamics (5 papers). Fei Peng is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers) and Microtubule and mitosis dynamics (5 papers). Fei Peng collaborates with scholars based in China, United States and United Kingdom. Fei Peng's co-authors include Quentin Liu, Eric W.‐F. Lam, Bai Cui, Jie Xu, Xu Hou, Fei-Meng Zheng, Yunke Bi, Shiguang Zhao, Bin He and Keith W. Kelley and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Analytical Chemistry.

In The Last Decade

Fei Peng

47 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fei Peng China 22 1.0k 529 291 285 199 49 1.7k
Nicola Perrotti Italy 30 1.4k 1.4× 304 0.6× 156 0.5× 228 0.8× 195 1.0× 92 2.4k
Mauricio Berriel Díaz Germany 26 1.2k 1.2× 368 0.7× 223 0.8× 269 0.9× 571 2.9× 45 2.5k
Xiangyu Liu China 23 840 0.8× 312 0.6× 163 0.6× 219 0.8× 515 2.6× 72 2.1k
Yichao Zhu China 27 1.2k 1.2× 544 1.0× 201 0.7× 380 1.3× 94 0.5× 92 2.0k
Minying Zheng China 24 981 1.0× 611 1.2× 174 0.6× 315 1.1× 150 0.8× 57 1.6k
Paul Smith United Kingdom 16 1.1k 1.1× 351 0.7× 174 0.6× 458 1.6× 758 3.8× 31 1.9k
Peng Huang China 25 862 0.9× 321 0.6× 89 0.3× 364 1.3× 154 0.8× 82 1.8k
Guangmei Yan China 29 1.1k 1.1× 379 0.7× 125 0.4× 476 1.7× 107 0.5× 107 2.1k
Eduardo Pérez Salazar Mexico 27 1.1k 1.1× 699 1.3× 244 0.8× 364 1.3× 112 0.6× 60 1.9k
Takashi Yagi Japan 26 914 0.9× 242 0.5× 129 0.4× 239 0.8× 136 0.7× 114 1.6k

Countries citing papers authored by Fei Peng

Since Specialization
Citations

This map shows the geographic impact of Fei Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Peng more than expected).

Fields of papers citing papers by Fei Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Peng. The network helps show where Fei Peng may publish in the future.

Co-authorship network of co-authors of Fei Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Peng. A scholar is included among the top collaborators of Fei Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Peng. Fei Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Peng, Fei, et al.. (2025). Integrating cancer medicine into metabolic rhythms. Trends in Endocrinology and Metabolism. 36(11). 1014–1028. 2 indexed citations
3.
Tian, Hao, J. R. Gao, Yichi Chen, et al.. (2025). Self-propelled ferroptosis nanoinducer for enhanced cancer therapy. International Journal of Extreme Manufacturing. 7(3). 35501–35501. 4 indexed citations
4.
Zhang, Yuxuan, Yezhong Wang, Jialin Du, et al.. (2025). Biomimetic immortalized mesenchymal stem cell-based nanoparticles suppress orthotopic postsurgical glioma via CD73 targeting and chemotherapy. Journal of Controlled Release. 388(Pt 1). 114297–114297.
5.
Peng, Fei, Huanhuan Cao, Xueqin Li, et al.. (2024). Abstract 2712: Development of GB268, a tri-specific antibody targeting PD-1/CTLA-4/VEGF, with enhanced anti-tumor efficacy and reduced toxicity in pre-clinical studies. Cancer Research. 84(6_Supplement). 2712–2712. 1 indexed citations
6.
Lü, Jinxin, Xiaoyu Zhang, Congcong Liu, et al.. (2024). Olanzapine suppresses mPFC activity-norepinephrine releasing to alleviate CLOCK-enhanced cancer stemness under chronic stress. Cell Communication and Signaling. 22(1). 375–375. 7 indexed citations
7.
Cui, Bai, Bin He, Yanping Huang, et al.. (2023). Pyrroline-5-carboxylate reductase 1 reprograms proline metabolism to drive breast cancer stemness under psychological stress. Cell Death and Disease. 14(10). 682–682. 17 indexed citations
8.
Zhou, Lei, et al.. (2023). Exploring novel biomarkers in dilated cardiomyopathy‑induced heart failure by integrated analysis and in vitro experiments. Experimental and Therapeutic Medicine. 26(1). 325–325. 10 indexed citations
9.
Sun, Shulan, Wei Zhou, Xiaoxi Li, et al.. (2021). Nuclear Aurora kinase A triggers programmed death‐ligand 1‐mediated immune suppression by activating MYC transcription in triple‐negative breast cancer. Cancer Communications. 41(9). 851–866. 33 indexed citations
10.
Wang, Peng, Ying Gong, Tao Guo, et al.. (2019). Activation of Aurora A kinase increases YAP stability via blockage of autophagy. Cell Death and Disease. 10(6). 432–432. 52 indexed citations
11.
Li, Xiaojie, Miaomiao Shao, Bai Cui, et al.. (2018). Downregulation of miR-218-5p promotes invasion of oral squamous cell carcinoma cells via activation of CD44-ROCK signaling. Biomedicine & Pharmacotherapy. 106. 646–654. 39 indexed citations
12.
Zhang, Weiguang, Yunke Bi, Jianhua Li, et al.. (2017). Long noncoding RNA FTX is upregulated in gliomas and promotes proliferation and invasion of glioma cells by negatively regulating miR-342-3p. Laboratory Investigation. 97(4). 447–457. 48 indexed citations
13.
Peng, Fei, Tingting Li, Wenjun Fan, et al.. (2017). H19/let-7/LIN28 reciprocal negative regulatory circuit promotes breast cancer stem cell maintenance. Cell Death and Disease. 8(1). e2569–e2569. 203 indexed citations
14.
Paul, Jinny, Juan E. Abrahante, Ying Wang, et al.. (2017). Transcriptomic analysis of gene signatures associated with sickle pain. Scientific Data. 4(1). 170051–170051. 8 indexed citations
15.
Peng, Fei, et al.. (2016). CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis. PLoS ONE. 11(9). e0163678–e0163678. 12 indexed citations
16.
Bi, Yunke, Chen Shen, Chenguang Li, et al.. (2015). Inhibition of autophagy induced by quercetin at a late stage enhances cytotoxic effects on glioma cells. Tumor Biology. 37(3). 3549–3560. 52 indexed citations
17.
Hou, Xu, Yaohua Liu, Huailei Liu, et al.. (2015). PERK silence inhibits glioma cell growth under low glucose stress by blockage of p-AKT and subsequent HK2's mitochondria translocation. Scientific Reports. 5(1). 9065–9065. 60 indexed citations
18.
Li, Chenguang, Yaohua Liu, Huailei Liu, et al.. (2015). Impact of Autophagy Inhibition at Different Stages on Cytotoxic Effect of Autophagy Inducer in Glioblastoma Cells. Cellular Physiology and Biochemistry. 35(4). 1303–1316. 55 indexed citations
19.
Liu, Huailei, Weiguang Zhang, Kaikai Wang, et al.. (2014). Methionine and cystine double deprivation stress suppresses glioma proliferation via inducing ROS/autophagy. Toxicology Letters. 232(2). 349–355. 48 indexed citations
20.
Peng, Fei, et al.. (2011). The effect of noncoherent red light irradiation on proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells. Lasers in Medical Science. 27(3). 645–653. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026